Tetrasodium (3Z)-5-Amino-4-Oxo-6-[4-(2-Sulfonatooxyethylsulfonyl)Phenyl]Diazenyl-3-[[4-(2-Sulfonatoo
Get a Quick Quote Now
Select Packaging
Product Description
Product
Tetrasodium (3Z)-5-Amino-4-Oxo-6-[4-(2-Sulfonatooxyethylsulfonyl)Phenyl]Diazenyl-3-[[4-(2-Sulfonatoo
CAS
90598-98-4
Formula
C26H21N5Na4O19S6; C26H25N5O19S6.4Na
Synonym
Reactive Black 5; Na; Other Registry Numbers 1208234-88-1; Primazin Black BN; Registry Numbers ?CAS Registry Number 17095-24-8; Remazol Black B; Remazol Black GF; Sumifix Black B; Superlist Name 2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-3,6-bis((p-((2-hydroxyethyl)sulfonyl)phenyl)azo)-, 3,6-bis(hydrogen sulfate) (ester), tetrasodium salt; System Generated Number 0017095248; Tetrasodium 4-amino-5-hydroxy-3,6-bis((4-((2-(sulphonatooxy)ethyl)sulphonyl)phenyl)azo)naphthalene-2,7-disulphonate; UNII-O0HDY58362; 12225-25-1; 136511-39-2; 188735-39-9; 2,7-Naphthalenedisulfonic acid, 3,6-(bis(4-((2-hydroxyethyl)sulfonyl)phenyl)bis(azo))-5-amino-4-hydroxy-, di(hydrogen sulfate) ester, tetrasodium salt; 2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-3,6-bis((4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)azo)-, tetrasodium salt; 2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-3,6-bis(2-(4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)diazenyl)-, sodium salt (1:4); 403597-90-0; 4-Amino-5-hydroxy-3,6-bis((4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)azo)-2,7-naphthalenedisulfonic acid tetrasodium salt; 72528-69-9; 90598-98-4; C.I. 20505; C.I. Reactive Black 5; Cavalite Black B; CCRIS 9492; Celmazol Black B; CI REACTIVE BLACK 5; COMPONENT; Diamira Black B; Drimarene Black R/K 3B; EC 241-164-5; EINECS 241-164-5; FDA UNII O0HDY58362; Intracron Black VS-B; Levafix Black E-B; Molecular Formula Fragments C26-H25-N5-O19-S6; Molecular Formulas ?Molecular Formula C26-H25-N5-O19-S6.4Na
Typical Product Specifications
SMILES
c12c(cc(S(=O)(=O)[O-])c(c1N)\N=N\c1ccc(S(CCOS(=O)(=O)[O-])(=O)=O)cc1)cc(S(=O)(=O)[O-])c(c2O)\N=N\c1ccc(S(CCOS(=O)(=O)[O-])(=O)=O)cc1.[Na+].[Na+].[Na+].[Na+]
InChI
HFIYIRIMGZMCPC-YOLJWEMLSA-J
InChIKey
1S/C26H25N5O19S6.4Na/c27-23-22-15(13-20(53(37,38)39)24(23)30-28-16-1-5-18(6-2-16)51(33,34)11-9-49-55(43,44)45)14-21(54(40,41)42)25(26(22)32)31-29-17-3-7-19(8-4-17)52(35,36)12-10-50-56(46,47)48;;;;/h1-8,13-14,32H,9-12,27H2,(H,37,38,39)(H,40,41,42)(H,4
Class
Tetrasodium (3Z)-5-Amino-4-Oxo-6-[4-(2-Sulfonatooxyethylsulfonyl)Phenyl]Diazenyl-3-[[4-(2-Sulfonatoo
Product Description
Product
Tetrasodium (3Z)-5-Amino-4-Oxo-6-[4-(2-Sulfonatooxyethylsulfonyl)Phenyl]Diazenyl-3-[[4-(2-Sulfonatoo
CAS
90598-98-4
Formula
C26H21N5Na4O19S6; C26H25N5O19S6.4Na
Synonym
Reactive Black 5; Na; Other Registry Numbers 1208234-88-1; Primazin Black BN; Registry Numbers ?CAS Registry Number 17095-24-8; Remazol Black B; Remazol Black GF; Sumifix Black B; Superlist Name 2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-3,6-bis((p-((2-hydroxyethyl)sulfonyl)phenyl)azo)-, 3,6-bis(hydrogen sulfate) (ester), tetrasodium salt; System Generated Number 0017095248; Tetrasodium 4-amino-5-hydroxy-3,6-bis((4-((2-(sulphonatooxy)ethyl)sulphonyl)phenyl)azo)naphthalene-2,7-disulphonate; UNII-O0HDY58362; 12225-25-1; 136511-39-2; 188735-39-9; 2,7-Naphthalenedisulfonic acid, 3,6-(bis(4-((2-hydroxyethyl)sulfonyl)phenyl)bis(azo))-5-amino-4-hydroxy-, di(hydrogen sulfate) ester, tetrasodium salt; 2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-3,6-bis((4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)azo)-, tetrasodium salt; 2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-3,6-bis(2-(4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)diazenyl)-, sodium salt (1:4); 403597-90-0; 4-Amino-5-hydroxy-3,6-bis((4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)azo)-2,7-naphthalenedisulfonic acid tetrasodium salt; 72528-69-9; 90598-98-4; C.I. 20505; C.I. Reactive Black 5; Cavalite Black B; CCRIS 9492; Celmazol Black B; CI REACTIVE BLACK 5; COMPONENT; Diamira Black B; Drimarene Black R/K 3B; EC 241-164-5; EINECS 241-164-5; FDA UNII O0HDY58362; Intracron Black VS-B; Levafix Black E-B; Molecular Formula Fragments C26-H25-N5-O19-S6; Molecular Formulas ?Molecular Formula C26-H25-N5-O19-S6.4Na
Typical Product Specifications
SMILES
c12c(cc(S(=O)(=O)[O-])c(c1N)\N=N\c1ccc(S(CCOS(=O)(=O)[O-])(=O)=O)cc1)cc(S(=O)(=O)[O-])c(c2O)\N=N\c1ccc(S(CCOS(=O)(=O)[O-])(=O)=O)cc1.[Na+].[Na+].[Na+].[Na+]
InChI
HFIYIRIMGZMCPC-YOLJWEMLSA-J
InChIKey
1S/C26H25N5O19S6.4Na/c27-23-22-15(13-20(53(37,38)39)24(23)30-28-16-1-5-18(6-2-16)51(33,34)11-9-49-55(43,44)45)14-21(54(40,41)42)25(26(22)32)31-29-17-3-7-19(8-4-17)52(35,36)12-10-50-56(46,47)48;;;;/h1-8,13-14,32H,9-12,27H2,(H,37,38,39)(H,40,41,42)(H,4
Class
